PRAX Q4 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$28,000

Operating Income

-$97M

Net Income

-$89M

EPS (Diluted)

$-3.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$77M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$938M

Total Liabilities

$60M

Stockholders' Equity

$878M

Cash & Equivalents

$357M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$7M	-100.0%
Gross Profit	-$28,000	-$49M	+99.9%
Operating Income	-$97M	-$64M	-51.7%
Net Income	-$89M	-$59M	-51.5%